PDSB
PDSB
NASDAQ · Biotechnology

Pds Biotechnology Corp

$0.54
-0.10 (-15.42%)
As of Mar 29, 10:51 PM ET ·
Financial Highlights (FY 2025)
Revenue
7.82M
Net Income
-1,043,017
Gross Margin
44.6%
Profit Margin
-13.3%
Rev Growth
-3.5%
D/E Ratio
1.41
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 44.6% 44.6% 44.6%
Operating Margin -8.7% -9.6% -8.4%
Profit Margin -13.3% -12.5% -12.9%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 7.82M 7.64M 6.13M
Gross Profit 3.49M 3.40M 2.73M
Operating Income -680,621 -735,643 -513,798
Net Income -1,043,017 -954,590 -792,337
Gross Margin 44.6% 44.6% 44.6%
Operating Margin -8.7% -9.6% -8.4%
Profit Margin -13.3% -12.5% -12.9%
Rev Growth -3.5% +15.6% +20.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 21.34M 20.87M 17.34M
Total Equity 15.18M 15.06M 16.26M
D/E Ratio 1.41 1.39 1.07
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -1,028,959 -906,364 -702,614
Free Cash Flow -801,636 -705,541 -523,657